GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Net Income (Continuing Operations)

IMGT (XKRX:456570) Net Income (Continuing Operations) : ₩4,082.37 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. IMGT's Net Income (Continuing Operations) for the six months ended in Dec. 2023 was ₩4,082.37 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,082.37 Mil.

IMGT Net Income (Continuing Operations) Historical Data

The historical data trend for IMGT's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Net Income (Continuing Operations) Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
-6,622.87 -16,912.67 731.32 4,082.37

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations) -6,622.87 -16,912.67 731.32 4,082.37

IMGT Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,082.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMGT  (XKRX:456570) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

IMGT Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of IMGT's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

IMGT Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Net Income (Continuing Operations)
Comparable Companies
XKRX:036480 XKRX:208340 XKRX:115180 XKRX:344860 XKRX:383930 XKRX:298060 XKRX:065650 XKRX:299660 XKRX:179530 XKRX:142760 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
Website
http://www.imgt.co.kr
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines